


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-5.65%
+0.64%
+3.34%
+0.45%
VYGR
Voyager Therapeutics
$4.18
Strengths

Upgraded on attractively valued

Trading below its fair value
Chart
$4.66 (-10.30%)
$3.36 (+24.40%)
$3.2 (+30.63%)
$6.46 (-35.29%)
VYGR has Fair risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Price under $5

High volatilty

VYGR overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Trading below its fair value
![]()
VYGR Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
VYGR Street Sentiment is bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is VYGR current stock price?
What are VYGR stock strengths?
What is VYGR Risk Level?
What is VYGR market cap and volume?
What is VYGR current Stock IQ?
Should I buy VYGR stock right now?
Is VYGR a Strong Buy right now?
What does a 'Strong Buy' rating mean for VYGR?
What does a 'Strong Sell' rating mean for VYGR?
What factors influence VYGR's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-5.65%
+0.64%
+3.34%
+0.45%
VYGR
Voyager Therapeutics
Current Price
$4.18
Stock Insights
Strengths

Upgraded on attractively valued

Trading below its fair value

Chart
$4.66 (-10.30%)
$3.36 (+24.40%)
$3.2 (+30.63%)
$6.46 (-35.29%)
VYGR Analysts Opinion
VYGR Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Trading below its fair value
![]()
VYGR Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
VYGR Street Sentiment is bullish and have positive views on the near-term outlook
VYGR has Fair risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Price under $5

High volatilty

Average key support and resistance price levels.
VYGR Latest Analysis
Voyager Technologies (VOYG) Positioned to Benefit from Growth in Defense and Space Markets Says Keybanc. Voyager Technologies Inc. (NYSE:VOYG) is among the 8 Best Small-Cap Defense Stocks to Buy Right Now. However on November 6 Keybanc slashed its price target for the stock to $45 from $50 citing conservatism surrounding a prolonged government shutdown. However the firm maintained its Overweight rating on the stock and noted that the company was [….]
Wed Nov 19, 2025
Top 3 Industrials Stocks That Are Set To Fly In Q4. The most oversold stocks in the industrials sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator which compares a stock’.s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’.s price action it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30 ac
Wed Nov 19, 2025
HC Wainwright & Co. Maintains Voyager Therapeutics (VYGR) Buy Recommendation. Fintel reports that on November 12 2025 HC Wainwright &. Co. maintained coverage of Voyager Therapeutics (NasdaqGS:VYGR) with a Buy recommendation. Analyst Price Forecast Suggests 275.12% Upside
Thu Nov 13, 2025
Voyager Therapeutics GAAP EPS of -$0.47 beats by $0.05 revenue of $13.37M beats by $5.51M.
Mon Nov 10, 2025
Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia. CAMBRIDGE United Kingdom and LEXINGTON Mass. Nov. 10 2025 (GLOBE NEWSWIRE) -- Transition Bio a drug discovery company focused on unlocking traditionally undruggable targets by leveraging biomolecular condensates and Voyager Therapeutics (Nasdaq: VYGR) a biotechnology company dedicated to leveraging genetics to treat neurological diseases have entered into a drug disco
Mon Nov 10, 2025
Keybanc Maintains Voyager Technologies (VOYG) Overweight Recommendation. Fintel reports that on November 6 2025 Keybanc maintained coverage of Voyager Technologies (NYSE:VOYG) with a Overweight recommendation. Analyst Price Forecast Suggests 98.65% Upside
Fri Nov 7, 2025
Voyager Technologies prices $435M convertible debt offering.
Fri Nov 7, 2025
Voyager Technologies announces $300M convertible senior notes offering.
Wed Nov 5, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
VYGR Stock trends
VYGR Stock performance
VYGR Stock analysis
VYGR investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.